HC Wainwright & Co. Maintains Buy on Biora Therapeutics, Adjusts Price Target To $23 (1-10 Reverse Stock Split)

Benzinga11/19 02:00

Biora Therapeutics Shares Are Trading Lower. The Stock May Be Moving on Continued Weakness Following a Q3 Earnings Miss and a Year-over-year Decline in Revenue Reported on Thursday

Benzinga11/16 04:31

ビオラ・セラピューティクス・インク | 10-Q：Q3 2024 四半期報告書

SEC11/15 05:17

Biora Therapeutics Q3 2024 GAAP EPS From Continuing Operations $(6.08) May Not Be Comparable To $(3.85) Estimate, Sales $32.00K Miss $210.00K Estimate

Benzinga11/15 05:16

ビオラ・セラピューティクス・インク | 8-K：Biora Therapeuticsは、企業の最新情報を提供し、2024年第3四半期の決算を報告します

SEC11/15 05:12

Here Are the Major Earnings After the Close Today

Seeking Alpha11/14 23:00